SRR_accession	QC_summary	SRX_accession	SRS_accession	SRP_accession	Experiment_title	GEO_series
SRR33396239	PASS	SRX28639022	SRS24909584	SRP582563	GSM8964998: PL19-45-liver,oncogene induced primary HCC tumor model, treated with antibody; Mus musculus; RNA-Seq	GSE296090
SRR33396240	WARN(1,5,7)	SRX28639021	SRS24909583	SRP582563	GSM8964997: P11-45-liver,oncogene induced primary HCC tumor model, treated with antibody; Mus musculus; RNA-Seq	GSE296090
SRR33396242	PASS	SRX28639019	SRS24909581	SRP582563	GSM8964995: PL19-3-liver,oncogene induced primary HCC tumor model, treated with antibody; Mus musculus; RNA-Seq	GSE296090
SRR33396244	WARN(1,5,7)	SRX28639017	SRS24909579	SRP582563	GSM8964993: P111-3-liver,oncogene induced primary HCC tumor model, treated with antibody; Mus musculus; RNA-Seq	GSE296090
SRR33396247	WARN(1,5,7)	SRX28639014	SRS24909576	SRP582563	GSM8964990: P11-8-liver,oncogene induced primary HCC tumor model, treated with antibody; Mus musculus; RNA-Seq	GSE296090
SRR33396248	WARN(5)	SRX28639013	SRS24909575	SRP582563	GSM8964989: C18-45-liver,RAS/MYC HTVi induce tumor model without treatment; Mus musculus; RNA-Seq	GSE296090
SRR33396251	WARN(1,5,7)	SRX28639010	SRS24909572	SRP582563	GSM8964986: CV6-3-liver,RAS/MYC HTVi induce tumor model without treatment; Mus musculus; RNA-Seq	GSE296090
SRR33396253	WARN(1,5,7)	SRX28639008	SRS24909570	SRP582563	GSM8964984: C5-3-liver,RAS/MYC HTVi induce tumor model without treatment; Mus musculus; RNA-Seq	GSE296090
SRR33396254	FAIL(6)	SRX28639007	SRS24909569	SRP582563	GSM8964983: C18-8-liver,RAS/MYC HTVi induce tumor model without treatment; Mus musculus; RNA-Seq	GSE296090
SRR33396255	WARN(1,5,7)	SRX28639006	SRS24909568	SRP582563	GSM8964982: C5-8-liver,RAS/MYC HTVi induce tumor model without treatment; Mus musculus; RNA-Seq	GSE296090
SRR33396256	FAIL(4,6)	SRX28639005	SRS24909567	SRP582563	GSM8964981: C1-8-liver,RAS/MYC HTVi induce tumor model without treatment; Mus musculus; RNA-Seq	GSE296090
